JP2005504514A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005504514A5 JP2005504514A5 JP2002587627A JP2002587627A JP2005504514A5 JP 2005504514 A5 JP2005504514 A5 JP 2005504514A5 JP 2002587627 A JP2002587627 A JP 2002587627A JP 2002587627 A JP2002587627 A JP 2002587627A JP 2005504514 A5 JP2005504514 A5 JP 2005504514A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- nucleic acid
- cell
- acid molecule
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102000004196 processed proteins & peptides Human genes 0.000 claims 51
- 108090000765 processed proteins & peptides Proteins 0.000 claims 51
- 229920001184 polypeptide Polymers 0.000 claims 50
- 238000000034 method Methods 0.000 claims 33
- 150000007523 nucleic acids Chemical class 0.000 claims 29
- 108020004707 nucleic acids Proteins 0.000 claims 25
- 102000039446 nucleic acids Human genes 0.000 claims 25
- 210000004027 cell Anatomy 0.000 claims 23
- 239000000523 sample Substances 0.000 claims 15
- 239000000126 substance Substances 0.000 claims 11
- 241001465754 Metazoa Species 0.000 claims 10
- 125000003275 alpha amino acid group Chemical group 0.000 claims 9
- 201000010099 disease Diseases 0.000 claims 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 8
- 230000000694 effects Effects 0.000 claims 8
- 230000003902 lesion Effects 0.000 claims 8
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 4
- 239000013068 control sample Substances 0.000 claims 4
- 108700019146 Transgenes Proteins 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 3
- 239000002773 nucleotide Substances 0.000 claims 3
- 125000003729 nucleotide group Chemical group 0.000 claims 3
- 241000238631 Hexapoda Species 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 2
- 230000001594 aberrant effect Effects 0.000 claims 2
- 230000001580 bacterial effect Effects 0.000 claims 2
- 238000012258 culturing Methods 0.000 claims 2
- 210000004962 mammalian cell Anatomy 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 230000003334 potential effect Effects 0.000 claims 2
- 229940124606 potential therapeutic agent Drugs 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- 210000005253 yeast cell Anatomy 0.000 claims 2
- 230000001413 cellular effect Effects 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000012636 effector Substances 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 239000003550 marker Substances 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
Applications Claiming Priority (30)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28893501A | 2001-05-03 | 2001-05-03 | |
| US28908701P | 2001-05-07 | 2001-05-07 | |
| US28962001P | 2001-05-08 | 2001-05-08 | |
| US28962101P | 2001-05-08 | 2001-05-08 | |
| US28981801P | 2001-05-09 | 2001-05-09 | |
| US28981701P | 2001-05-09 | 2001-05-09 | |
| US29019401P | 2001-05-11 | 2001-05-11 | |
| US29075301P | 2001-05-14 | 2001-05-14 | |
| US29118901P | 2001-05-15 | 2001-05-15 | |
| US29124301P | 2001-05-16 | 2001-05-16 | |
| US29200101P | 2001-05-18 | 2001-05-18 | |
| US29237401P | 2001-05-21 | 2001-05-21 | |
| US29258701P | 2001-05-22 | 2001-05-22 | |
| US29310701P | 2001-05-23 | 2001-05-23 | |
| US29358901P | 2001-05-24 | 2001-05-24 | |
| US29374701P | 2001-05-25 | 2001-05-25 | |
| US29411001P | 2001-05-29 | 2001-05-29 | |
| US29443401P | 2001-05-30 | 2001-05-30 | |
| US31219201P | 2001-08-14 | 2001-08-14 | |
| US31317301P | 2001-08-17 | 2001-08-17 | |
| US31318701P | 2001-08-17 | 2001-08-17 | |
| US31872801P | 2001-09-12 | 2001-09-12 | |
| US31874401P | 2001-09-12 | 2001-09-12 | |
| US33591001P | 2001-11-15 | 2001-11-15 | |
| US33389101P | 2001-11-28 | 2001-11-28 | |
| US33394201P | 2001-11-28 | 2001-11-28 | |
| US34577602P | 2002-01-03 | 2002-01-03 | |
| US34522002P | 2002-01-04 | 2002-01-04 | |
| US13607102A | 2002-05-01 | 2002-05-01 | |
| PCT/US2002/014341 WO2002090568A2 (en) | 2001-05-03 | 2002-05-02 | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005504514A JP2005504514A (ja) | 2005-02-17 |
| JP2005504514A5 true JP2005504514A5 (enExample) | 2006-01-05 |
Family
ID=34280347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002587627A Withdrawn JP2005504514A (ja) | 2001-05-03 | 2002-05-02 | 治療用ポリペプチド、それをコードする核酸、および使用方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2005504514A (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117646029B (zh) * | 2023-11-21 | 2024-07-16 | 贵州大学 | TaSLC25A4-7A基因在小麦育种及提高抗逆能力中的应用 |
-
2002
- 2002-05-02 JP JP2002587627A patent/JP2005504514A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005512515A5 (enExample) | ||
| JP2003505075A5 (enExample) | ||
| Laurence et al. | The epidermal growth factor: a review of structural and functional relationships in the normal organism and in cancer cells | |
| Carson | Receptor for the group B coxsackieviruses and adenoviruses: CAR | |
| MX2008007324A (es) | Usos de antagonistas de miostatina. | |
| CN1334820A (zh) | 结缔组织生长因子片段及其方法和用途 | |
| CN102382172A (zh) | 抑制肌肉生长抑制素的结合剂 | |
| JPH08505765A (ja) | Ｅｃｋ受容体リガンド | |
| JP2004500037A5 (enExample) | ||
| JP2007312778A (ja) | ＨＭＧ蛋白質（ｈｉｇｈｍｏｂｉｌｉｔｙｇｒｏｕｐｐｒｏｔｅｉｎ）遺伝子の核酸配列およびそれらの使用 | |
| JP2003532742A (ja) | 神経損傷の修復 | |
| JP2001512667A (ja) | ヒトオーファンレセプターｎｔｒ−１ | |
| CA2522994A1 (en) | Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer | |
| JP2003528611A (ja) | β様糖タンパク質ホルモンのポリペプチドおよびヘテロ二量体 | |
| JP2005528080A5 (enExample) | ||
| JP2005504010A (ja) | 成長ホルモンおよびｆｏｘｍ１ｂを用いた肝臓疾患および肝臓損傷の処置方法 | |
| JP2004533235A5 (enExample) | ||
| JP2005506833A5 (enExample) | ||
| JP2005504514A5 (enExample) | ||
| KR19990087392A (ko) | 개 ob 단백질 조성물 및 방법 | |
| RU97104072A (ru) | Модуляторы веса тела, соответствующие нуклеиновые кислоты и протеины, а также их применение для диагностических и терапевтических целей | |
| JP2007519894A (ja) | 標的としてのカドヘリンの使用 | |
| JP2005528886A5 (enExample) | ||
| WO2002030974A2 (en) | Proteins and nucleic acids encoding same | |
| JP2002508934A (ja) | Ｔｎｆレセプターに対して相同性を有する、新規な核酸およびポリペプチド |